Join the Royal Society of Medicine Endocrinology and Diabetes Section for this obesity pharmacotherapy masterclass, a dedicated full-day event exploring the latest advances in the medical management of obesity and the rapidly evolving role of GLP-1-based treatments. Bringing together leading experts in obesity, endocrinology and cardiometabolic medicine, the programme combines the latest science with practical discussion to support evidence-based obesity care.
Obesity pharmacotherapy is transforming clinical practice, yet the pace of development means many healthcare professionals face challenges keeping up with emerging evidence and translating clinical trial findings into day-to-day care. This masterclass addresses that gap through expert-led sessions covering the science underpinning obesity treatments, efficacy and safety evidence, broader health outcomes, future therapies, and practical implementation within multidisciplinary clinical services.
This full-day masterclass is structured to bridge science and practice, with the morning session dedicated to the latest evidence in obesity pharmacotherapy and the afternoon focused on practical implementation in clinical care. Delegates will hear from experts on the evolving science of obesity, current and future treatments, and broader health outcomes, before moving into an interactive session exploring patient pathways, multidisciplinary support, service delivery and real-world clinical challenges. Dedicated breaks throughout the day will provide opportunities for discussion and networking with colleagues and speakers.
Why attend?
Aims of the event
Learning outcomes
Who should attend?
RSM members enjoy free access to over 200 expert-led events each year, including CPD-accredited learning.
Become a memberEarly bird pricing available until 12 October 2026.
| Day 1 |
|---|
|
£0.00
Meeting
£35.75
Lunch
(optional) |
| Day 1 |
|---|
|
£0.00
Meeting
£35.75
Lunch
(optional) |
| Day 1 |
|---|
|
£0.00
Meeting
£35.75
Lunch
(optional) |
| Day 1 |
|---|
|
£0.00
Meeting
£35.75
Lunch
(optional) |
| Day 1 |
|---|
|
£0.00
Meeting
£35.75
Lunch
(optional) |
| Consultant / GP / SAS Doctors | Other HCPs | Resident Doctor | Student |
|---|---|---|---|
| £141.00 | £84.00 | £84.00 | £44.00 |
Professor Alex Miras is Professor of Endocrinology at Ulster University. His clinical and research work focus solely on Obesity and type 2 diabetes. He has contributed to clinical management policy and research in the field of Obesity over the last 16 years. The specialist interests of his research Group are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices, and obesity surgery.
Chair: Professor Alex Miras, Professor of Endocrinology, Ulster University and Dr Helen Turner, President, Endocrinology & Diabetes Section, Royal Society of Medicine
Professor Carel le Roux, Professor of Metabolic Medicine, University College Dublin, Ireland
Dr Dimitris Papamargaritis, associate professor in Endocrinology, Leicester University, UK
Dr Susan Connolly, Consultant Cardiologist, University Hospital Galway, Ireland
Virtual presenter: Professor Naveed Satar, Professor of Cardiometabolic Medicine, University of Glasgow, UK
AGM for section members only
Chair: Dr Abdul Lakhdar, Consultant Endocrinologist, Whipps Cross University Hospital and Immediate past President, Endocrinology & Diabetes Section, Royal Society of Medicine
Initiation, titration, plateau, weight regain, special populations, grey cases
Dr Mick Crotty, General practitioner, My Best Weight, Dublin, Ireland
Nutritional support
Ms Gillian Galway, Obesity specialist dietitian, Belfast, UK
Psychological support
Dr Danieal Alves, Specialist clinical psychologist, Complex Obesity service - Colchester Hospital, East Suffolk North Essex NHS Foundation Trust, UK
Health coaching support
Ms Nikki Coughlan, Obesity specialist Health Coach
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registration for this event will close at 1:00 am on Monday 23 November 2026. Late registrations will not be accepted.
The agenda is subject to change.
Where the event is recorded, only presentations for which permission has been granted will be made available after the event. The availability of recordings is at the discretion of the speakers and the Royal Society of Medicine. Recordings may be distributed in the future via RSM digital channels.
All views expressed at this event are those of the individual speakers and do not necessarily reflect the views of the Royal Society of Medicine or the speakers’ organisations.
